Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ZYFLO

ZILEUTON

Standard Dose
300MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Discontinued
Summary

Approval overview ZYFLO is listed in Drugs@FDA under application 020471 (NDA).

Review priority: UNKNOWN Marketing status: Discontinued Active ingredient ZILEUTON Form and strength TABLET;ORAL - 300MG Sponsor CHIESI Submission history Latest submission status date: 2012-06-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview ZYFLO is listed in Drugs@FDA under application 020471 (NDA). Review priority: UNKNOWN Marketing status: Discontinued Active ingredient ZILEUTON Form and strength TABLET;ORAL - 300MG Sponsor CHIESI Submission history Latest submission status date: 2012-06-08 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: UNKNOWN

Interaction Notes

  • No interaction notes stored yet.